Cancer / Tumor Profiling Market - Global Industry Report, Share, Size and Forecast 2022-2027
IMARC Group’s latest research report, titled “ Cancer/Tumor Profiling Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027 ,” offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios. The global cancer tumor profiling market reached a value of US$ 9.38 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 18.22 Billion by 2027 exhibiting a CAGR of 11.20% during 2022-2027. Cancer/tumor profiling, or biomarker testing, is a laboratory test for identifying specific proteins, genes or gene mutations, and other biomarkers in a tumor tissue sample. It helps oncologists determine whether the pathways of an individual’s tumor match up with the available targeted therapies. It also assists in routine diagnostics, therapeutic decision-making, and creating person...